Patriot Financial Group Insurance Agency’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,626
| Closed | -$838K | – | 533 |
|
|
2025
Q2 | $838K | Sell |
6,626
-27
| -0.4% | -$3.31K | 0.1% | 233 |
|
|
2025
Q1 | $851K | Buy |
6,653
+4,339
| +188% | +$588K | 0.11% | 206 |
|
|
2024
Q4 | $306K | Sell |
2,314
-35
| -1% | -$4.92K | 0.04% | 367 |
|
|
2024
Q3 | $342K | Sell |
2,349
-64
| -3% | -$9.26K | 0.05% | 360 |
|
|
2024
Q2 | $331K | Sell |
2,413
-32
| -1% | -$4.27K | 0.05% | 345 |
|
|
2024
Q1 | $335K | Sell |
2,445
-3,449
| -59% | -$471K | 0.05% | 338 |
|
|
2023
Q4 | $801K | Sell |
5,894
-79
| -1% | -$9.64K | 0.15% | 159 |
|
|
2023
Q3 | $730K | Buy |
5,973
+118
| +2% | +$15K | 0.15% | 174 |
|
|
2023
Q2 | $743K | Buy |
5,855
+120
| +2% | +$15.6K | 0.14% | 170 |
|
|
2023
Q1 | $741K | Sell |
5,735
-77
| -1% | -$10.1K | 0.15% | 161 |
|
|
2022
Q4 | $763K | Sell |
5,812
-56
| -1% | -$7.24K | 0.1% | 142 |
|
|
2022
Q3 | $686K | Buy |
5,868
+89
| +2% | +$11.1K | 0.17% | 151 |
|
|
2022
Q2 | $680K | Buy |
5,779
+201
| +4% | +$23.9K | 0.14% | 157 |
|
|
2022
Q1 | $727K | Buy |
5,578
+1,283
| +30% | +$167K | 0.13% | 177 |
|
|
2021
Q4 | $656K | Sell |
4,295
-163
| -4% | -$25.2K | 0.11% | 193 |
|
|
2021
Q3 | $721K | Buy |
4,458
+374
| +9% | +$62.9K | 0.13% | 179 |
|
|
2021
Q2 | $668K | Buy |
4,084
+1,728
| +73% | +$266K | 0.12% | 182 |
|
|
2021
Q1 | $355K | Sell |
2,356
-146
| -6% | -$23.2K | 0.08% | 255 |
|
|
2020
Q4 | $379K | Buy |
2,502
+1,675
| +203% | +$239K | 0.1% | 219 |
|
|
2020
Q3 | $112K | Sell |
827
-29
| -3% | -$3.93K | 0.04% | 368 |
|
|
2020
Q2 | $117K | Buy |
856
+100
| +13% | +$12.7K | 0.04% | 321 |
|
|
2020
Q1 | $81K | Sell |
756
-50
| -6% | -$5.76K | 0.04% | 350 |
|
|
2019
Q4 | $97K | Sell |
806
-224
| -22% | -$25K | 0.04% | 346 |
|
|
2019
Q3 | $103K | Hold |
1,030
| – | – | 0.05% | 301 |
|
|
2019
Q2 | $115K | Sell |
1,030
-153
| -13% | -$16.3K | 0.05% | 290 |
|
|
2019
Q1 | $132K | Buy |
1,183
+735
| +164% | +$80.6K | 0.07% | 223 |
|
|
2018
Q4 | $43K | Sell |
448
-75
| -14% | -$7.96K | 0.03% | 348 |
|
|
2018
Q3 | $64K | Buy |
523
+78
| +18% | +$9.19K | 0.04% | 267 |
|
|
2018
Q2 | $49K | Sell |
445
-1
| -0.2% | -$107 | 0.05% | 185 |
|
|
2018
Q1 | $46K | Hold |
446
| – | – | 0.03% | 328 |
|
|
2017
Q4 | $49K | Sell |
446
-49
| -10% | -$5.24K | 0.04% | 303 |
|
|
2017
Q3 | $56K | Buy |
495
+150
| +43% | +$16K | 0.05% | 236 |
|
|
2017
Q2 | $36K | Hold |
345
| – | – | 0.04% | 301 |
|
|
2017
Q1 | $33K | Hold |
345
| – | – | 0.03% | 284 |
|
|
2016
Q4 | $31K | Buy |
+345
| New | +$31.4K | 0.04% | 289 |
|
Other funds holding IBB
CB
Patriot Financial Group Insurance Agency's IBB Position: Q3 2025 in Review
Patriot Financial Group Insurance Agency sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 6,626 shares — an estimated $838K sold.
Patriot Financial Group Insurance Agency first reported a position in IBB in Q4 2016 and held it in 35 quarters. The position peaked at $851K in Q1 2025. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.
- Patriot Financial Group Insurance Agency reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
- Patriot Financial Group Insurance Agency sold 6,626 iShares Biotechnology ETF shares in Q3 2025, an estimated $838K.
- Patriot Financial Group Insurance Agency first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 35 quarters.
- Patriot Financial Group Insurance Agency's iShares Biotechnology ETF position peaked at $851K in Q1 2025.
- 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2025, filed 8 Oct 2025.